Search research articles
Contact Us
Filters
Showing results (341-350 of 443) with videos related to
Page
of 45
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 10, 2005
Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1
Kaye J Williams, Brian A Telfer, Dia Xenaki, et al.
Cancer Letters
|
February 27, 2007
Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma
Fion L Sung, Edwin P Hui, Qian Tao, et al.
Journal of Extracellular Biology
|
June 28, 2024
ELTD1 is present in extracellular vesicles derived from endothelial cells as a cleaved extracellular domain which induces in vivo angiogenesis
Helen Sheldon, Wei Zhang, Esther Bridges, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2011
Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer
Adrian M Jubb, Kathy D Miller, Hope S Rugo, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
January 19, 2006
Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease
Silvia Colucci, Giulia Taraboletti, Luca Primo, et al.
Cancer Research
|
May 23, 2002
Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation
Kevin J Turner, John W Moore, Adam Jones, et al.
Cancer Cell
|
July 19, 2002
HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron
Stefano J Mandriota, Kevin J Turner, David R Davies, et al.
Molecular Cancer
|
February 13, 2014
Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia
Carme Camps, Harpreet K Saini, David R Mole, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
January 31, 2013
Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts
Krishan Kumar, Simon Wigfield, Harriet E Gee, et al.
Critical Reviews in Oncology/Hematology
|
July 1, 2023
The impact of survivorship bias in glioblastoma research
Francesco Pasqualetti, Alessandro Barberis, Sofia Zanotti, et al.
Page
of 45
Search research articles
Search
Showing results (341-350 of 443) with videos related to
Sort By:
Page
of 45
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 10, 2005
Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1
Kaye J Williams, Brian A Telfer, Dia Xenaki, et al.
Cancer Letters
|
February 27, 2007
Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma
Fion L Sung, Edwin P Hui, Qian Tao, et al.
Journal of Extracellular Biology
|
June 28, 2024
ELTD1 is present in extracellular vesicles derived from endothelial cells as a cleaved extracellular domain which induces in vivo angiogenesis
Helen Sheldon, Wei Zhang, Esther Bridges, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2011
Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer
Adrian M Jubb, Kathy D Miller, Hope S Rugo, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
January 19, 2006
Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease
Silvia Colucci, Giulia Taraboletti, Luca Primo, et al.
Cancer Research
|
May 23, 2002
Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation
Kevin J Turner, John W Moore, Adam Jones, et al.
Cancer Cell
|
July 19, 2002
HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron
Stefano J Mandriota, Kevin J Turner, David R Davies, et al.
Molecular Cancer
|
February 13, 2014
Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia
Carme Camps, Harpreet K Saini, David R Mole, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
January 31, 2013
Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts
Krishan Kumar, Simon Wigfield, Harriet E Gee, et al.
Critical Reviews in Oncology/Hematology
|
July 1, 2023
The impact of survivorship bias in glioblastoma research
Francesco Pasqualetti, Alessandro Barberis, Sofia Zanotti, et al.
Page
of 45